Jasmin Barman-Aksözen

13PUBLICATIONS
23CO-AUTHORS
PharmacogenomicsOncology and carcinogenesis not elsewhere classifiedHaematologyEpidemiological methodsHeterodox economics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|May 19, 2026
Access to orphan drugs in adults with inherited metabolic diseases in Switzerland: a single-center retrospective cohort study.

|Mar 26, 2026
New and currently investigated pharmacotherapies for the erythropoietic protoporphyrias: spotlight on dersimelagon and bitopertin.

Jasmin Barman-Aksözen, Francesca Granata, Sebastian Wäscher

|Dec 30, 2025
New pharmacotherapies for the erythropoietic protoporphyrias: an analysis of trial protocols from a patient perspective.

Cornelia Dechant, Sebastian Wäscher, Francesca Granata

|Oct 30, 2025
Letter to the Editor - Qualitative evidence submitted by patients to NICE: need for more quality or unrealistic and unfair requirements?

Rocco Falchetto, Jasmin Barman-Aksözen

|Jul 16, 2024
Erythropoietic protoporphyrias: Pathogenesis, diagnosis and management.

Anna-Elisabeth Minder, Louisa G Kluijver, Jasmin Barman-Aksözen

|May 25, 2024
Fair Funding Decisions: Consistency of the Time Horizons Used in the Calculation of Quality-Adjusted Life Years for Therapies for Very Rare Diseases by the National Institute for Health and Care Excellence in England.

Jasmin Barman-Aksözen, Nicole Hentschel, Mårten Pettersson

Pageof 3

Frequent Collaborators

5 joint publications

Rocco Falchetto

4 joint publications

Cornelia Dechant

3 joint publications

Mårten Pettersson

3 joint publications

Mehmet Hakan Aksözen